Home » Topics » Conferences

Conferences
RSS

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...